Physician profile
Benjamin Saks
NPI 1003235516
$36,344.86
in general payments reported to CMS, 2019-2025
15 companies · $782 in 2025
The $782 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $9,293 · 2021: $14K · 2022: $1,454 · 2023: $366 · 2024: $226 · 2025: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,295 · Travel and Lodging: $79.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,295.22 |
| Travel and Lodging | $79.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,172.36 | 2019-2021 | |
| Smith+Nephew, INC. | $7,611.81 | 2020-2023 | Trigen Intertan, Evos |
| Medwest Associates | $3,845.99 | 2020-2021 | |
| Kairos Surgical INC | $2,580.11 | 2021-2023 | |
| Stryker Corporation | $1,315.29 | 2021-2025 | Mako, Restoration, Gamma |
| Pacira Pharmaceuticals Incorporated | $182.13 | 2021-2023 | Iovera |
| Medacta USA, INC. | $123.16 | 2020 | |
| Anika Therapeutics, INC. | $112.63 | 2020 | |
| Skeletal Dynamics INC | $106.57 | 2025 | Align, Implate, Ijs |
| Pacira Therapeutics, INC. | $98.17 | 2021 | |
| Acumed LLC | $82.89 | 2020 | |
| Depuy Synthes Sales INC. | $49.20 | 2021-2023 | Orthovisc, Monovisc |
| Abbvie INC. | $37.50 | 2021-2022 | |
| Ethicon US, LLC | $14.26 | 2025 | Ethicon, Vistaseal, Surgiflo Hemostatic Matrix |
| Si-Bone, INC. | $12.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Saks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.